Bcrx ah trades
WebWilliam P Sheridan - BCRX / BioCryst Pharmaceuticals, Inc. - Insider Trade Report EXTENDED This page shows the track record and history of Sheridan William P insider trades in BioCryst Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. WebBCRX : 8.68 (+1.76%) Wall Street Analysts Predict a 48% Upside in BioCryst (BCRX): Here's What You Should Know Zacks - Wed Jan 4, 8:55AM CST. The mean of analysts' price targets for BioCryst (BCRX) points to a 47.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among …
Bcrx ah trades
Did you know?
WebReal-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Close Trending Tickers bar WebView the latest BioCryst Pharmaceuticals Inc. (BCRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. BCRX BioCryst Pharmaceuticals …
WebFind the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock quote, history, news and other vital information to help you with your stock trading and investing. WebBioCryst Pharmaceuticals, Inc. (BCRX) Stock Price, News, Quote & History - Yahoo Finance Dow 30 Nasdaq +91.09(+0.76%) Russell 2000 +2.33(+0.13%) Crude Oil -0.24( …
WebApr 12, 2024 · BCRX Insider Trading Activity BioCryst Pharmaceuticals Insider Buys and Sells NASDAQ:BCRX BioCryst Pharmaceuticals - BCRX Insider Trading & Ownership … WebView BCRX historial stock data and compare to other stocks and exchanges. BioCryst Pharmaceuticals Inc. advanced stock charts by MarketWatch. Skip to main content Main …
WebApr 5, 2024 · BioCryst Pharma. (BCRX) is scheduled to report earnings on May 4, 2024.The last reported earnings were for reported on February 21, 2024 for Q4.
WebStock Price Target BCRX Advertisement Options Overview Research & Ratings Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume... the barber of seville english translationWebFeb 9, 2024 · BCRX is a biotech company that specializes in oral prophylactic treatments for rare diseases. The company already has a drug on the market called Orladeyo, which was FDA approved in 2024 to treat... the guardian brexit articleWebMar 31, 2024 · The stock currently trades at $79.67 and it is a top-three stake at ~12% of the portfolio. There was a ~5% stake increase this quarter at ~$72 per share. Note: … the guardian britainWeb102 rows · BioCryst Pharmaceuticals, Inc. (BCRX) Stock Historical Prices & Data - Yahoo Finance U.S. markets close in 4 hours 22 minutes Dow 30 +83.53(+0.25%) Nasdaq … the barber of seville - overtureWebBioCryst Pharmaceuticals, Inc. (BCRX) Stock Historical Prices & Data - Yahoo Finance U.S. markets close in 4 hours 22 minutes Dow 30 +83.53(+0.25%) Nasdaq 12,014.30 -70.05(-0.58%) Russell 2000... the barber of seville story summaryWebBioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company that discovers novel, oral, and small-molecule medicines. The firm focuses on the treatment of rare … the guardian boris johnson resignsWebApr 3, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCRX shares currently have a short interest ratio of 10.0. Learn More on BioCryst Pharmaceuticals's short interest ratio. the guardian brexit latest